首页> 美国卫生研究院文献>Scientific Data >Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequency
【2h】

Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequency

机译:可变等位基因频率可变的肿瘤中体细胞TP53突变的综合分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Somatic mutation of the tumor suppressor gene TP53 is reported in at least 50% of human malignancies. Most high-grade serous ovarian cancers (HGSC) have a mutant TP53 allele. Accurate detection of these mutants in heterogeneous tumor tissue is paramount as therapies emerge to target mutant p53. We used a Fluidigm Access Array™ System with Massively Parallel Sequencing (MPS) to analyze DNA extracted from 76 serous ovarian tumors. This dataset has been made available to researchers through the European Genome-phenome Archive (EGA; EGAS00001002200). Herein, we present analyses of this dataset using HaplotypeCaller and MuTect2 through the Broad Institute’s Genome Analysis Toolkit (GATK). We anticipate that this TP53 mutation dataset will be useful to researchers developing and testing new software to accurately determine high and low frequency variant alleles in heterogeneous aneuploid tumor tissue. Furthermore, the analysis pipeline we present provides a valuable framework for determining somatic variants more broadly in tumor tissue.
机译:据报道,至少50%的人类恶性肿瘤中存在抑癌基因TP53的体细胞突变。大多数高级浆液性卵巢癌(HGSC)具有突变型TP53等位基因。随着靶向突变体p53的治疗方法的出现,在异质肿瘤组织中准确检测这些突变体至关重要。我们使用带有大规模并行测序(MPS)的Fluidigm Access Array™系统来分析从76个浆液性卵巢肿瘤中提取的DNA。该数据集已通过欧洲基因组-现象库(EGA; EGAS00001002200)提供给研究人员。在此,我们通过Broad Institute的基因组分析工具包(GATK)使用HaplotypeCaller和MuTect2对该数据集进行了分析。我们预计该TP53突变数据集将对研究人员开发和测试新软件以准确确定异质非整倍体肿瘤组织中的高频和低频变异等位基因很有用。此外,我们提出的分析流程为在肿瘤组织中更广泛地确定体细胞变异提供了有价值的框架。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号